107 related articles for article (PubMed ID: 19572243)
1. Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib.
Frieling T; Heise J; Wassilew SW
Dtsch Med Wochenschr; 2009 Jul; 134(28-29):e1-2, 1464-6. PubMed ID: 19572243
[TBL] [Abstract][Full Text] [Related]
2. Multiple colon perforation as a fatal complication during treatment of metastatic melanoma with ipilimumab - case report.
Dilling P; Walczak J; Pikiel P; Kruszewski WJ
Pol Przegl Chir; 2014 Feb; 86(2):94-6. PubMed ID: 24670341
[TBL] [Abstract][Full Text] [Related]
3. Severe sorafenib-induced hand-foot skin reaction.
Cuesta L; Betlloch I; Toledo F; Latorre N; Monteagudo A
Dermatol Online J; 2011 May; 17(5):14. PubMed ID: 21635836
[TBL] [Abstract][Full Text] [Related]
4. Colon perforation during sorafenib therapy for advanced hepatocelluar carcinoma. A case report.
Park SG; Chung CH; Park CY
Tumori; 2011; 97(6):794-9. PubMed ID: 22322848
[TBL] [Abstract][Full Text] [Related]
5. Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect.
Lopez V; Pinazo I; Marti N; Monteagudo C; Jorda E
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):959-60. PubMed ID: 18785888
[No Abstract] [Full Text] [Related]
6. Does basal cell carcinoma belong to the spectrum of sorafenib-induced epithelial skin cancers?
Degen A; Satzger I; Voelker B; Kapp A; Hauschild A; Gutzmer R
Dermatology; 2010; 221(3):193-6. PubMed ID: 20720388
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib and surgical complications: a case report of adverse reaction to sorafenib during treatment for renal cell carcinoma.
Eng FC; Easson AM; Szentgyorgyi E; Knox JJ
Eur J Surg Oncol; 2009 Feb; 35(2):219-21. PubMed ID: 17976949
[No Abstract] [Full Text] [Related]
8. Bowel perforation after radiotherapy in a patient receiving sorafenib.
Peters NA; Richel DJ; Verhoeff JJ; Stalpers LJ
J Clin Oncol; 2008 May; 26(14):2405-6. PubMed ID: 18467733
[No Abstract] [Full Text] [Related]
9. Sorafenib-induced erythema multiforme.
MacGregor JL; Silvers DN; Grossman ME; Sherman WH
J Am Acad Dermatol; 2007 Mar; 56(3):527-8. PubMed ID: 17241689
[No Abstract] [Full Text] [Related]
10. Eruptive keratoacanthoma-type squamous cell carcinomas in patients taking sorafenib for the treatment of solid tumors.
Smith KJ; Haley H; Hamza S; Skelton HG
Dermatol Surg; 2009 Nov; 35(11):1766-70. PubMed ID: 19660024
[TBL] [Abstract][Full Text] [Related]
11. Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.
Blumenschein GR; Gatzemeier U; Fossella F; Stewart DJ; Cupit L; Cihon F; O'Leary J; Reck M
J Clin Oncol; 2009 Sep; 27(26):4274-80. PubMed ID: 19652055
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib: delivering a targeted drug to the right targets.
Flaherty KT
Expert Rev Anticancer Ther; 2007 May; 7(5):617-26. PubMed ID: 17492926
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib-induced premalignant and malignant skin lesions.
Williams VL; Cohen PR; Stewart DJ
Int J Dermatol; 2011 Apr; 50(4):396-402. PubMed ID: 21413947
[TBL] [Abstract][Full Text] [Related]
14. [Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations].
Boige V; Barbare JC; Rosmorduc O;
Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):3-7. PubMed ID: 18341970
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
[TBL] [Abstract][Full Text] [Related]
16. [Clinical observation of 21 cases of metastatic renal cell carcinoma treated with sorafenib].
Xie XD; Piao Y; Liu ZZ
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):714-5. PubMed ID: 20021872
[No Abstract] [Full Text] [Related]
17. Transient perforating folliculitis induced by sorafenib.
Minami-Hori M; Ishida-Yamamoto A; Komatsu S; Iiduka H
J Dermatol; 2010 Sep; 37(9):833-4. PubMed ID: 20883372
[No Abstract] [Full Text] [Related]
18. Sorafenib: a promising new targeted therapy for renal cell carcinoma.
Wood LS; Manchen B
Clin J Oncol Nurs; 2007 Oct; 11(5):649-56. PubMed ID: 17962173
[TBL] [Abstract][Full Text] [Related]
19. Clinical management and case reports for the treatment of hepatocellular carcinoma with sorafenib.
Frenette CT; Frederick RT; Gish RG
J Clin Gastroenterol; 2011 Sep; 45(8):733-7. PubMed ID: 20930642
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials.
Zhang T; Ding X; Wei D; Cheng P; Su X; Liu H; Wang D; Gao H
Anticancer Drugs; 2010 Mar; 21(3):326-32. PubMed ID: 20016366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
